trial · primary record
YF550
Solid Tumor (Phase I)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 204 |
| Primary completion | 2029-09 |
| Primary endpoint | The occurrence and frequency of Treatment-emergent adverse events (TEAEs) |
| Registry ID | NCT07894874 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:58.058Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07894874
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.